Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intensive hospital monitoring of adverse drug reactions for Wuling capsule
ChiCTR-ONC-13003245Phase 4Completed
- Sponsor
- Beijing University of Chinese Medicine East Hospital
- Start
- Jun 2013
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of wulingshen in Insomnia, sponsored by Beijing University of Chinese Medicine East Hospital. Primary endpoint: Incidence of severe adverse drug reactions. Started Jun 2013; status: completed.
02
Drugs
wulingshen
03
Conditions
Insomnia
Beyond the preview
Go deeper on ChiCTR-ONC-13003245.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-ONC-13003245.